세포 및 유전자 공급망 서비스 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 기술별, 용도별, 최종사용자 지역별, 경쟁별 세분화(2020-2030년)
Cell and Gene Supply Chain Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology, By Applications, By End User Region and Competition, 2020-2030F
상품코드:1886378
리서치사:TechSci Research
발행일:2025년 12월
페이지 정보:영문 183 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 세포·유전자 치료 공급망 서비스 시장은 2024년에 14억 4,000만 달러로 평가되며, 2030년까지 CAGR 9.85%로 성장하며, 25억 3,000만 달러에 달할 것으로 예측됩니다. 세계 세포-유전자치료제 공급망 서비스 시장은 환자 검체 채취부터 투여까지 제품 품질을 보장하기 위해 섬세한 세포-유전자치료제 운송에 필요한 전문적인 물류, 취급 및 관리된 보관을 포함합니다. 이 시장의 성장은 주로 임상시험을 거쳐 규제 당국의 승인을 받은 첨단 치료제 증가와 바이오의약품 혁신에 대한 대규모 투자에 의해 지원되고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
14억 4,000만 달러
시장 규모 : 2030년
25억 3,000만 달러
CAGR : 2025-2030년
9.85%
가장 빠르게 성장하는 부문
물류
최대 시장
북미
주요 시장 성장 촉진요인
세포 및 유전자 치료 기술의 발전은 새로운 물류상의 복잡성을 가져옴으로써 공급망 서비스 시장에 큰 영향을 미치고 있습니다. 유전자 편집 툴와 첨단 전달 시스템의 발전으로 정밀한 유전자 변형과 치료 용도의 확대가 가능해지면서 고도로 전문화된 콜드체인 관리 및 운송이 필요하게 되었습니다.
주요 시장 과제
견고하고 통합된 세계 극저온 물류 인프라를 구축하고 유지하기 위한 복잡한 요구사항은 세계 세포 및 유전자 공급망 서비스 시장에 큰 장벽으로 작용하고 있습니다. 이러한 첨단 치료법은 환자의 시료 채취부터 최종 투여까지 제품의 무결성을 유지하기 위해 초저온 보관과 정확하고 중단 없는 온도 관리 운송이 요구됩니다.
주요 시장 동향
강화된 디지털 추적성 및 공급망 최적화는 첨단 기술을 활용하여 공급망 전체에 대한 실시간 가시성과 제어를 실현하는 데 초점을 맞추었습니다. 세포 및 유전자 치료의 개별화 및 시간적 제약의 특성을 고려할 때, 환자 샘플의 채취부터 투여까지 재료의 정확한 추적은 제품의 무결성과 환자의 안전을 유지하는 데 매우 중요합니다.
목차
제1장 개요
제2장 조사 방법
제3장 개요
제4장 고객의 소리
제5장 세계의 세포·유전자 공급망 서비스 시장 전망
시장 규모·예측
금액별
시장 점유율·예측
기술별(클라우드 환경, 온프레미스 환경)
용도별(주문·스케줄 관리, 검체 수집, 물류, 치료 후 팔로 업)
최종사용자별(바이오뱅크/세포은행, 병원, 연구기관, 세포치료 연구소, 기타)
지역별
기업별(2024)
시장 맵
제6장 북미의 세포·유전자 공급망 서비스 시장 전망
시장 규모·예측
시장 점유율·예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 세포·유전자 공급망 서비스 시장 전망
시장 규모·예측
시장 점유율·예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 세포·유전자 공급망 서비스 시장 전망
시장 규모·예측
시장 점유율·예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 세포·유전자 공급망 서비스 시장 전망
시장 규모·예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
남아프리카공화국
제10장 남미의 세포·유전자 공급망 서비스 시장 전망
시장 규모·예측
시장 점유율·예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
촉진요인
과제
제12장 시장 동향과 발전
합병·인수
제품 출시
최근 동향
제13장 세계의 세포·유전자 공급망 서비스 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 힘
고객의 힘
대체품의 위협
제15장 경쟁 구도
Biocair International Limited
Arvato SE
Associated Couriers, LLC.
TrakCel Limited
Parkoursc Inc.
DHL
McKesson Corporation
Almac Group Limited
Catalent Inc.
Biostor Ltd.
제16장 전략적 제안
제17장 조사회사 소개·면책사항
KSA
영문 목차
영문목차
The Global Cell and Gene Supply Chain Services Market , valued at USD 1.44 Billion in 2024, is projected to experience a CAGR of 9.85% to reach USD 2.53 Billion by 2030. The Global Cell and Gene Supply Chain Services Market involves the specialized logistics, handling, and controlled storage necessary for transporting sensitive cell and gene therapies, ensuring product integrity from patient sample collection through to administration. The market's growth is predominantly supported by the increasing number of these advanced therapies progressing through clinical trials and receiving regulatory approvals, coupled with significant investments in biopharmaceutical innovation.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 1.44 Billion
Market Size 2030
USD 2.53 Billion
CAGR 2025-2030
9.85%
Fastest Growing Segment
Logistics
Largest Market
North America
Key Market Drivers
Advancements in cell and gene therapy technologies significantly influence the supply chain services market by introducing novel logistical complexities. The evolution of gene editing tools and advanced delivery systems enables precise genetic modifications and expanded therapeutic applications, necessitating highly specialized cold chain management and transport.
Key Market Challenges
The intricate requirement for establishing and maintaining a robust, globally integrated cryogenic logistics infrastructure presents a significant impediment to the Global Cell and Gene Supply Chain Services Market. These advanced therapies demand ultra-cold storage and precise, uninterrupted temperature-controlled transportation to preserve product integrity from patient sample collection through final administration. The technical complexity and specialized equipment necessary for such rigorous cold chain management across diverse geographic regions create substantial operational hurdles for service providers.
Key Market Trends
Enhanced Digital Traceability and Supply Chain Optimization focuses on leveraging advanced technologies to achieve real-time visibility and control across the entire supply chain. Given the personalized and time-sensitive nature of cell and gene therapies, accurate tracking of materials from patient sample collection to administration is paramount for maintaining product integrity and patient safety. Digitalization and real-time tracking technologies can significantly minimize supply chain risks by enhancing product visibility throughout the value chain.
Key Market Players
Biocair International Limited
Arvato SE
Associated Couriers, LLC.
TrakCel Limited
Parkoursc Inc.
DHL
McKesson Corporation
Almac Group Limited
Catalent Inc.
Biostor Ltd.
Report Scope:
In this report, the Global Cell and Gene Supply Chain Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Cell and Gene Supply Chain Services Market , By Technology:
Presence on cloud
Presence on-premises
Cell and Gene Supply Chain Services Market , By Applications:
Ordering and scheduling
Sample collection
Logistics
Post treatment follow-up
Cell and Gene Supply Chain Services Market , By End-User:
Biobank/ cell-bank
Hospitals
Research institutes
Cell therapy labs
Others
Cell and Gene Supply Chain Services Market , By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Cell and Gene Supply Chain Services Market .
Available Customizations:
Global Cell and Gene Supply Chain Services Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Cell and Gene Supply Chain Services Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Technology (Presence on cloud, Presence on-premises)
5.2.2. By Applications (Ordering and scheduling, Sample collection, Logistics, Post treatment follow-up)
5.2.3. By End-User (Biobank/ cell-bank, Hospitals, Research institutes, Cell therapy labs, Others)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. North America Cell and Gene Supply Chain Services Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Technology
6.2.2. By Applications
6.2.3. By End-User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Cell and Gene Supply Chain Services Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Technology
6.3.1.2.2. By Applications
6.3.1.2.3. By End-User
6.3.2. Canada Cell and Gene Supply Chain Services Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Technology
6.3.2.2.2. By Applications
6.3.2.2.3. By End-User
6.3.3. Mexico Cell and Gene Supply Chain Services Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Technology
6.3.3.2.2. By Applications
6.3.3.2.3. By End-User
7. Europe Cell and Gene Supply Chain Services Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Technology
7.2.2. By Applications
7.2.3. By End-User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Cell and Gene Supply Chain Services Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Technology
7.3.1.2.2. By Applications
7.3.1.2.3. By End-User
7.3.2. France Cell and Gene Supply Chain Services Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Technology
7.3.2.2.2. By Applications
7.3.2.2.3. By End-User
7.3.3. United Kingdom Cell and Gene Supply Chain Services Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Technology
7.3.3.2.2. By Applications
7.3.3.2.3. By End-User
7.3.4. Italy Cell and Gene Supply Chain Services Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Technology
7.3.4.2.2. By Applications
7.3.4.2.3. By End-User
7.3.5. Spain Cell and Gene Supply Chain Services Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Technology
7.3.5.2.2. By Applications
7.3.5.2.3. By End-User
8. Asia Pacific Cell and Gene Supply Chain Services Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Technology
8.2.2. By Applications
8.2.3. By End-User
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Cell and Gene Supply Chain Services Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Technology
8.3.1.2.2. By Applications
8.3.1.2.3. By End-User
8.3.2. India Cell and Gene Supply Chain Services Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Technology
8.3.2.2.2. By Applications
8.3.2.2.3. By End-User
8.3.3. Japan Cell and Gene Supply Chain Services Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Technology
8.3.3.2.2. By Applications
8.3.3.2.3. By End-User
8.3.4. South Korea Cell and Gene Supply Chain Services Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Technology
8.3.4.2.2. By Applications
8.3.4.2.3. By End-User
8.3.5. Australia Cell and Gene Supply Chain Services Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Technology
8.3.5.2.2. By Applications
8.3.5.2.3. By End-User
9. Middle East & Africa Cell and Gene Supply Chain Services Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Technology
9.2.2. By Applications
9.2.3. By End-User
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Cell and Gene Supply Chain Services Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Technology
9.3.1.2.2. By Applications
9.3.1.2.3. By End-User
9.3.2. UAE Cell and Gene Supply Chain Services Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Technology
9.3.2.2.2. By Applications
9.3.2.2.3. By End-User
9.3.3. South Africa Cell and Gene Supply Chain Services Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Technology
9.3.3.2.2. By Applications
9.3.3.2.3. By End-User
10. South America Cell and Gene Supply Chain Services Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Technology
10.2.2. By Applications
10.2.3. By End-User
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Cell and Gene Supply Chain Services Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Technology
10.3.1.2.2. By Applications
10.3.1.2.3. By End-User
10.3.2. Colombia Cell and Gene Supply Chain Services Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Technology
10.3.2.2.2. By Applications
10.3.2.2.3. By End-User
10.3.3. Argentina Cell and Gene Supply Chain Services Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Technology
10.3.3.2.2. By Applications
10.3.3.2.3. By End-User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Cell and Gene Supply Chain Services Market : SWOT Analysis
